world cancer report - iarc
world cancer report - iarc
world cancer report - iarc
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
infected cells, whilst oncoproteins E6 and<br />
E7 interfere with the functions of negative<br />
cellular regulators, including p53 and pRb<br />
(Oncogenes and tumour suppressor<br />
genes, p96). Integration of the viral<br />
genome, deregulation of oncogene expression<br />
and other cofactors may all contribute<br />
to malignant progression (Fig. 2.43).<br />
A few other viruses are directly linked to<br />
human <strong>cancer</strong>, including EBV, HTLV-1 and<br />
HHV-8. EBV infects B lymphocytes and<br />
expression of viral protein is believed to<br />
induce what would otherwise be antigendriven<br />
lymphocyte activation. The immortalization-associated<br />
viral proteins regulate<br />
the maintenance of the episomal viral<br />
DNA and the expression of viral genes, as<br />
Fig. 2.47 The burden of <strong>cancer</strong> caused by infectious agents in women.<br />
Fig. 2.48 The burden of <strong>cancer</strong> caused by infectious agents in men.<br />
well as driving cellular proliferation and<br />
blocking apoptosis. It is believed that a<br />
crucial role in the transformation and<br />
immortalization of infected cells is played<br />
by the EBNA-2 protein. Malarial infection<br />
may be a cofactor in the progression of<br />
Burkitt lymphoma. HTLV-1 is able to<br />
immortalize human T lymphocytes in vitro.<br />
Central to this property is the HTLV-1 Tax<br />
protein which, via interference with several<br />
classes of transcription factors, activates<br />
the expression of some cellular<br />
genes involved in the control of cellular<br />
proliferation. HHV-8 is the most recentlyidentified<br />
tumour-causing virus and its<br />
role in pathogenesis is still poorly understood<br />
[7, 13].<br />
Carrier<br />
_<br />
Immune response<br />
Chronic hepatitis<br />
Mitogenesis Mutagenesis<br />
Cellular DNA<br />
damage, chromosomal<br />
abnormalities,<br />
genetic mutations<br />
HBV Infection<br />
Secondary events<br />
Loss of cellular growth control<br />
Hepatocellular<br />
carcinoma<br />
Fig. 2.49 Hepatitis B virus and the chronic injury<br />
hypothesis. A vigorous immune response to hepatitis<br />
B virus (+++) leads to viral clearance while<br />
an absent immune response (-) leads to the<br />
“healthy” carrier state and an intermediate<br />
response (+) produces chronic hepatitis which, via<br />
a multistep process, may eventually lead to hepatocellular<br />
carcinoma.<br />
The second, or indirect, mechanism is the<br />
mode of action for some viruses (HBV, HCV,<br />
HIV), bacteria (H. pylori) and parasites.<br />
These agents provoke <strong>cancer</strong> by causing<br />
chronic inflammation and/or production of<br />
mutagenic compounds. The hepatitis viruses,<br />
for example, are unable to immortalize<br />
human cells in vitro, but infection may lead<br />
to <strong>cancer</strong> via induction of chronic liver injury<br />
and hepatitis (Fig. 2.49). Chronic hepatitis<br />
caused by an intermediate immune<br />
response to HBV infection is characterized<br />
by chronic liver cell necrosis which stimulates<br />
a sustained regenerative response. The<br />
inflammatory component includes activated<br />
macrophages which are a rich source of free<br />
radicals. The collaboration of these mitogenic<br />
and mutagenic stimuli has the potential<br />
to cause cellular and viral DNA damage,<br />
chromosomal abnormalities and genetic<br />
mutations that deregulate cellular growth<br />
control in a multistep process that eventually<br />
leads to hepatocellular carcinoma.<br />
A prolonged process, lasting decades,<br />
precedes emergence of most gastric <strong>cancer</strong>s.<br />
H. pylori is the most frequent cause<br />
of chronic gastritis. Gastritis and atrophy<br />
+<br />
+++<br />
Clearance<br />
Viral DNA damage<br />
integration into host<br />
genome,<br />
X gene activation<br />
Chronic infections 59